YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering

This study is currently recruiting participants.
Verified January 2014 by Mount Sinai School of Medicine
Sponsor:
Collaborators:
Texas Heart Institute (Wafic Said Molecular Cardiology Research Lab)
Astrazeneca (direct)
InfraReDx (indirect)
Information provided by (Responsible Party):
Annapoorna Kini, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT01837823
First received: April 5, 2013
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)